JZP-341
- Generic Name
- JZP-341
A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Jazz Pharmaceuticals
- Target Recruit Count
- 12
- Registration Number
- NCT05631327
- Locations
- 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸SCRI HealthOne, Denver, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath